Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.

Lawren VandeVredeRenaud La JoieSheena HorikiNidhi S MundadaMary KoestlerJi-Hye HwangPeter A LjubenkovJulio C RojasGil D RabinoviciAdam L BoxerWilliam W Seeley

Published in: Acta neuropathologica (2023)

Keyphrases

cancer therapy
metabolic syndrome
skeletal muscle
weight loss